Effect of haloperidol and clozapine on (+)SKF 10,047-induced dopamine release: role of 5-HT3 receptors

Eur J Pharmacol. 1992 Mar 17;213(1):163-4. doi: 10.1016/0014-2999(92)90250-8.

Abstract

(+)SKF 10,047 preferentially increased dopamine release in the nucleus accumbens compared to the striatum. Dopamine output was evaluated in the same freely moving rats by trans-cerebral dialysis. Clozapine and DAU 6215, a 5HT3 antagonist, which itself did not modify dopamine release in both areas, selectively antagonized (+)SKF 10,047-induced dopamine release in the nucleus accumbens. Haloperidol by itself increased dopamine release in both areas and these effects were additive with those induced by (+)SKF 10,047.

MeSH terms

  • Animals
  • Brain / drug effects*
  • Brain / metabolism
  • Clozapine / pharmacology*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dopamine / metabolism*
  • Haloperidol / pharmacology*
  • Male
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / metabolism
  • Phenazocine / analogs & derivatives*
  • Phenazocine / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Receptors, Serotonin / metabolism*

Substances

  • Receptors, Serotonin
  • SK&F 10047
  • Phenazocine
  • Clozapine
  • Haloperidol
  • Dopamine